Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,100 | -1,390 | -6,080 | -3,620 | -1,900 |
| Depreciation Amortization | 80 | 40 | 140 | 100 | 60 |
| Other Working Capital | -1,320 | -1,340 | 310 | 430 | 140 |
| Other Operating Activity | 0 | 0 | 200 | 100 | 110 |
| Operating Cash Flow | $-4,340 | $-2,690 | $-5,430 | $-2,990 | $-1,590 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -30 | -250 | -140 | -120 |
| Other Investing Activity | 10,310 | 7,270 | -6,480 | -8,470 | -9,540 |
| Investing Cash Flow | $10,260 | $7,240 | $-6,730 | $-8,610 | $-9,660 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | -3 | -3 | -2 |
| Other Financing Activity | 130 | 110 | 13,083 | 12,963 | 12,932 |
| Financing Cash Flow | $130 | $110 | $13,080 | $12,960 | $12,930 |
| Beginning Cash Position | 1,110 | 1,110 | 200 | 200 | 200 |
| End Cash Position | 7,170 | 5,780 | 1,110 | 1,550 | 1,880 |
| Net Cash Flow | $6,050 | $4,670 | $910 | $1,350 | $1,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,340 | -2,690 | -5,430 | -2,990 | -1,590 |
| Free Cash Flow | -4,340 | -2,690 | -5,430 | -2,990 | -1,590 |